Human ST2/IL-33R Antibody Summary
Lys19-Phe328
Accession # BAA02233
Applications
Human/Primate ST2/IL-33 R Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
IFN-gamma Secretion Induced by IL‑33 and Neutralization by Human ST2/IL-33 R Antibody. Recombinant Human IL-33 induces IFN-gamma secretion in Human Peripheral Blood Mononuclear cells (PBMC) in the presence of Recombinant Human IL-12 (Catalog # 219-IL) in a dose-dependent manner (orange line), as measured by the Human IFN-gamma Quantikine ELISA Kit (Catalog # DIF50C). Under these conditions, IFN-gamma secretion elicited by IL-33 is neutralized (green line) by increasing concentrations of Mouse Anti-Human/Primate ST2/IL-33 R Monoclonal Antibody (Catalog # MAB523). The ND50 is typically 0.3-1.5 µg/mL.
Detection of Human ST2/IL-33R by Immunocytochemistry/Immunofluorescence Immunolocalization of ST2 in colonic tissue from responder and non-responder patients during baseline and 6-month follow-up. a Total ST2 immunoreactivity was restricted to the cellular infiltrate in the lamina propria at 6 months in responder patients (right), while in patients showing reactivation, total ST2 was increased in inflamed mucosa, also confined to the cellular infiltrate (left); baseline examination revealed extensive immune cell infiltration of the intestinal mucosa and damaged tissue with loss of architecture. b Total ST2 immunoreactivity at 6 months expressed as arbitrary units (A.U.) and normalized to baseline levels in responders and non-responders (n = 4 in each group) was higher in the non-responders. Hoechst 33342/ ST2 (blue/green) (60X) Image collected and cropped by CiteAb from the following publication (https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-016-0520-6), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: ST2/IL-33R
ST2, also known as IL-33R, IL-1 R4 and T1, is an Interleukin-1 receptor family glycoprotein that contributes to Th2 immune responses (1, 2). Human ST2 consists of a 310 amino acid (aa) extracellular domain (ECD) with three Ig-like domains, a 21 aa transmembrane segment, and a 207 aa cytoplasmic domain with an intracellular TIR domain (3, 4). Alternate splicing of the 120 kDa human ST2 generates a soluble 60 kDa isoform that lacks the transmembrane and cytoplasmic regions as well as an isoform that additionally lacks the third Ig‑like domain (4). Within the ECD, human ST2 shares 68% and 64% aa sequence identity with mouse and rat ST2, respectively. ST2 is expressed on the surface of mast cells, activated Th2 cells, macrophages, and cardiac myocytes (5‑8). It binds IL-33, a cytokine that is upregulated by inflammation or mechanical strain in smooth muscle cells, airway epithelia, keratinocytes, and cardiac fibroblasts (5, 9). IL-33 binding induces the association of ST2 with IL-1R AcP, a shared signaling subunit that also associates with IL-1 RI and IL-1 R rp2 (1, 10, 11). In macrophages, ST2 interferes with signaling from IL-1 RI and TLR4 by sequestering the adaptor proteins MyD88 and Mal (7). In addition to its role in promoting mast cell and Th2 dependent inflammation, ST2 activation enhances antigen induced hypernociception and protects from atherosclerosis and cardiac hypertrophy (5, 12‑14). The soluble ST2 isoform is released by activated Th2 cells and strained cardiac myocytes and is elevated in the serum in allergic asthma (6, 8, 15). Soluble ST2 functions as a decoy receptor that blocks IL‑33's ability to signal through transmembrane ST2 (10, 13‑15).
-
Barksby, H.E. et al. (2007) Clin. Exp. Immunol. 149:217.
-
Gadina, M. and C.A. Jefferies (2007) Science STKE 2007:pe31.
-
Tominaga, S. et al. (1992) Biochim. Biophys. Acta 1171:215.
-
Li, H. et al. (2000) Genomics 67:284.
-
Schmitz, J. et al. (2005) Immunity 23:479.
-
Lecart, S. et al. (2002) Eur. J. Immunol. 32:2979.
-
Brint, E.K. et al. (2004) Nat. Immunol. 5:373.
-
Weinberg, E.O. et al. (2002) Circulation 106:2961.
-
Sanada S. et al. (2007) J. Clin. Invest. 117:1538.
-
Palmer, G. et al. (2008) Cytokine 42:358.
-
Chackerian, A.A. et al. (2007) J. Immunol. 179:2551.
-
Allakhverdi, Z. et al. (2007) J. Immunol. 179:2051.
-
Verri Jr., W.A. et al. (2008) Proc. Natl. Acad. Sci. 105:2723.
-
Miller, A.M. et al. (2008) J. Exp. Med. 205:339.
-
Hayakawa, H. et al. (2007) J. Biol. Chem. 282:26369.
Product Datasheets
Citations for Human ST2/IL-33R Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
11
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
High-dimensional profiling clusters asthma severity by lymphoid and non-lymphoid status
Authors: MJ Camiolo, X Zhou, TB Oriss, Q Yan, M Gorry, W Horne, JB Trudeau, K Scholl, W Chen, JK Kolls, P Ray, FJ Weisel, NM Weisel, N Aghaeepour, K Nadeau, SE Wenzel, A Ray
Cell Reports, 2021-04-13;35(2):108974.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry, Mass Cytometry -
Combinatorial IL-17RB, ST2, and TSLPR Signaling in Dendritic Cells of Patients With Allergic Rhinitis
Authors: Rui Zheng, Yang Chen, Jianbo Shi, Kai Wang, Xuekun Huang, Yueqi Sun et al.
Frontiers in Cell and Developmental Biology
-
Type 2 innate lymphoid cells participate in IL‑33‑stimulated Th2‑associated immune response in chronic obstructive pulmonary disease
Authors: Min Jiang, Simin Tao, Shaohua Zhang, Jing Wang, Fengbo Zhang, Fengsen Li et al.
Experimental and Therapeutic Medicine
-
From proteomics to discovery of first-in-class ST2 inhibitors active in vivo
Authors: AM Ramadan, E Daguindau, JC Rech, K Chinnaswam, J Zhang, GL Hura, B Griesenaue, Z Bolten, A Robida, M Larsen, JA Stuckey, CY Yang, S Paczesny
JCI Insight, 2018-07-26;3(14):.
Species: Human
Sample Types: Recombinant Protein
Applications: AlphaLISA -
Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway
Authors: CW Wu, YG Wu, C Cheng, ZD Hong, ZM Shi, SQ Lin, J Li, XY He, AY Zhu
Cell. Physiol. Biochem., 2018-05-10;47(1):191-200.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis
Authors: D Díaz-Jimén, L Núñez, M De la Fuen, K Dubois-Cam, H Sepúlveda, M Montecino, A Torres-Riq, P García-Gon, J Chnaiderma, A Vossenkamp, TT MacDonald, D Simian, MJ González, JA Cidlowski, R Quera, MA Hermoso
Sci Rep, 2017-08-31;7(1):10180.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
Authors: David Díaz-Jiménez, Marjorie De la Fuente, Karen Dubois-Camacho, Glauben Landskron, Janitza Fuentes, Tamara Pérez et al.
BMC Gastroenterology
-
IL-1 Family Members IL-18 and IL-33 Upregulate the Inflammatory Potential of Differentiated Human Th1 and Th2 Cultures.
Authors: Blom L, Poulsen L
J Immunol, 2012-10-01;189(9):4331-7.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Daily exposure to dust alters innate immunity.
Authors: Sahlander K, Larsson K, Palmberg L
PLoS ONE, 2012-02-15;7(2):e31646.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.
Authors: Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T
Clin. Exp. Allergy, 2012-02-01;42(2):218-28.
Species: Human
Sample Types: Whole Cells, Whole Tissue
Applications: IHC-Fr, Neutralization -
Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells.
Authors: Yasuo T, Kitaya K
Fertil. Steril., 2008-08-09;92(2):709-21.
Species: Human
Sample Types: Cell Lysates, Whole Tissue
Applications: IHC-P, Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human ST2/IL-33R Antibody
There are currently no reviews for this product. Be the first to review Human ST2/IL-33R Antibody and earn rewards!
Have you used Human ST2/IL-33R Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image